MedTrace Logo

Efficacy of Teeth Whitening Product Offerings in Adults

NCT04124068 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2020-02-05

No results posted yet for this study

Summary

This is a 30 day randomized, parallel comparative trial where participants with tooth shade of C2 or darker will be assigned to one of five groups. The participants will be evaluated for the difference in tooth shade, as determined by the digital VITA Easyshade V (provided by GLO) before the respective whitening regimen (baseline), immediately following the treatment period, and at 30 days (\~4 weeks) from end of the treatment intervention.

Conditions

  • Tooth Discoloration

Interventions

OTHER

Hydrogen peroxide teeth whitening gel

Hydrogen peroxide teeth whitening gel with concentrations ranging between 6% - 30%

DEVICE

GLO Brilliant Teeth Whitening Device

Intra-oral mouthpiece connected to a battery in order to generate light and heat to effect the whitening treatment.

DEVICE

GLO Lit Teeth Whitening Device

Intra-oral mouthpiece connected to a battery in order to generate light and heat to effect the whitening treatment.

DEVICE

GLO Science Professional Teeth Whitening Device

Intra-oral mouthpiece connected to a battery in order to generate light and heat to effect the whitening treatment.

Sponsors & Collaborators

  • Arizona School of Dentistry & Oral Health, A. T. Still University

    collaborator UNKNOWN

  • Glo Science, Inc.

    lead INDUSTRY

Principal Investigators

  • Ann Spolarich, RDH, PhD · Arizona School of Dentistry & Oral Health, A. T. Still University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2019-11-30
Completion
2019-12-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04124068 on ClinicalTrials.gov